Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Autor: Goldsmith KC; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Park JR; Seattle Children's Hospital, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA., Kayser K; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Malvar J; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA., Chi YY; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Groshen SG; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Villablanca JG; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Krytska K; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lai LM; Department of Radiology, University of Iowa Hospital and Clinics, Iowa City, IA, USA., Acharya PT; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Radiology, Children's Hospital Los Angeles, Los Angeles, CA, USA., Goodarzian F; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Radiology, Children's Hospital Los Angeles, Los Angeles, CA, USA., Pawel B; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Shimada H; Department of Pathology and Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Ghazarian S; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA., States L; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Marshall L; The Royal Marsden Hospital, London, UK.; The Institute of Cancer Research, London, UK., Chesler L; The Royal Marsden Hospital, London, UK.; The Institute of Cancer Research, London, UK., Granger M; Cook Children's Medical Center, Fort Worth, TX, USA., Desai AV; Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago, Chicago, IL, USA., Mody R; Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA., Morgenstern DA; Division of Haematology and Oncology, Hospital for Sick Children, Toronto, ON, Canada.; Department of Paediatrics, University of Toronto, Toronto, ON, Canada., Shusterman S; Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Macy ME; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA., Pinto N; Seattle Children's Hospital, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA., Schleiermacher G; RTOP (Recherche Translationelle en Oncologie Pédiatrique), INSERM U830, Research Center, PSL Research University, Institut Curie, Paris, France.; SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris, France., Vo K; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA., Thurm HC; Global Product Development, Clinical Pharmacology, Pfizer Oncology, Pfizer, Inc., New York, NY, USA., Chen J; Global Product Development, Clinical Pharmacology, Pfizer Oncology, Pfizer, Inc., New York, NY, USA., Liyanage M; Global Product Development, Clinical Pharmacology, Pfizer Oncology, Pfizer, Inc., New York, NY, USA., Peltz G; Global Product Development, Clinical Pharmacology, Pfizer Oncology, Pfizer, Inc., New York, NY, USA., Matthay KK; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, CA, USA., Berko ER; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Division of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petach Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Marachelian A; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Mossé YP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. mosse@chop.edu.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. mosse@chop.edu.

Publikováno v: Nature medicine [Nat Med] 2023 May; Vol. 29 (5), pp. 1092-1102. Date of Electronic Publication: 2023 Apr 03.

Medically Refractory Idiopathic Intracranial Hypertension and HIV: A Rare Association.

Autor: Gupta D; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Mehta A; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Shetty NA; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Pradeep R; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Mahendra JV; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Acharya PT; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India., Srinivasa R; Department of Neurology, Ramaiah Medical College, Bengaluru, Karnataka, India.

Publikováno v: Neurology India [Neurol India] 2022 Sep-Oct; Vol. 70 (5), pp. 2229-2230.

Study of cerebrospinal fluid levels of lactate, lactate dehydrogenase and adenosine deaminase in the diagnosis and outcome of acute meningitis.

Autor: Singh L; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India., Javali M; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India., Mehta A; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India., Pradeep R; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India., Srinivasa R; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India., Acharya PT; Department of Neurology, MS Ramaiah Medical College & Hospital, Bengaluru, India.

Publikováno v: Neurological research [Neurol Res] 2022 May; Vol. 44 (5), pp. 463-467. Date of Electronic Publication: 2021 Dec 01.

Assessment of germinal matrix hemorrhage on head ultrasound with deep learning algorithms.

Autor: Kim KY; Department of Radiology, Loma Linda University Medical Center, Loma Linda, CA, USA., Nowrangi R; Department of Radiology, Loma Linda University Medical Center, Loma Linda, CA, USA., McGehee A; Loma Linda University School of Medicine, Loma Linda, CA, USA., Joshi N; Loma Linda University School of Medicine, Loma Linda, CA, USA., Acharya PT; Loma Linda University School of Medicine, Loma Linda, CA, USA. pacharya@chla.usc.edu.; Department of Radiology, Children's Hospital Los Angeles, 4650 Sunset Blvd., Mailstop #81, Los Angeles, CA, 90027, USA. pacharya@chla.usc.edu.; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. pacharya@chla.usc.edu.

Publikováno v: Pediatric radiology [Pediatr Radiol] 2022 Mar; Vol. 52 (3), pp. 533-538. Date of Electronic Publication: 2022 Jan 22.